Table 2.
Results of Laboratory Investigation after LEN Administration.
| Hematology | Biochemistry | |||||||
| WBC | 4,490 | /μL | TP | 7.9 | g/dL | |||
| RBC | 467×104 | /μL | Alb | 4.0 | g/dL | |||
| Hb | 15.5 | g/dL | BUN | 15.0 | mg/dL | |||
| PLT | 16.8×104 | /μL | Cre | 0.9 | mg/dL | |||
| T-Bil | 1.1 | mg/dL | ||||||
| AST | 62 | IU/L | ||||||
| ALT | 76 | IU/L | ||||||
| Coagulation | LDH | 231 | IU/L | |||||
| PT | 105 | % | ALP | 361 | IU/L | |||
| APTT | 34.4 | s | γGTP | 211 | IU/L | |||
| CRP | 1.7 | mg/dL | ||||||
LEN: lenvatinib, WBC: white blood cell, RBC: red blood cell, Hb: hemoglobin, PLT: platelet, PT: prothrombin time, APTT: activated partial thromboplastin time, TP: total protein, Alb: albumin, BUN: blood urea nitrogen, Cre: creatinine, T-Bil: total bilirubin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactate dehydrogenase, ALP: alkaline phosphatase, γGTP: gamma-glutamyl transpeptidase, CRP: C-reactive protein, AFP: alpha-fetoprotein, AFP-L3: lectin-reactive alpha-fetoprotein, DCP: Des-gamma-carboxy prothrombin